US company Flavorx will make good tasting medicine a reality when
it expands its blockbuster medication flavours into the UK pharmacy
market, after a continuous stream of consumer and business
interest.
Degussa used CPhI in Madrid to preview its new flow distributor,
which reduces the time it takes manufacturers to remove unwanted
transition metals from active pharmaceutical ingredients (APIs), by
eliminating the filtration step.
Generex has escalated manufacturing capabilities to meet expected
demand for the first ever commercially available non-injectable
insulin product, to be launched in Ecuador at the end of the month.
Chemical company Lanxess, release its third quarter results that
show restructuring strategy is bearing fruit, with sales up and the
reduction of net financial debt that is supported by strong growth
in the chemical industry.
The Pharmaceutical Fine Chemicals Business of Clariant took the
opportunity to review new developments at the CPhI Expo in Madrid,
Spain, making announcements on new investments in facilities in
Europe and the US as well as new business...
Millipore Corporation today announced two tangential flow
filtration (TFF) products that allow researchers to efficiently
purify large volumes of protein-containing solutions that
accelerate drug screening and improve sample preparation.
Vasogen announced preclinical data this week, demonstrating the
ability of its lead drug candidate to modulate key signalling
pathways associated with inflammation, demonstrating therapeutic
potential in a range of neurological disorders.
Schering-Plough has entered into an agreement with Oncomethylome
Sciences (OMS), which allows the pharma giants to use OMS
Pharmacogenomic technology to study MGMT methylation status in
brain cancer patients.
The Association of the British Pharmaceutial Industry (ABPI) has
revealed a new code of practice for the pharmaceutical industry,
with an emphasis on patient safety especially material detailing
information about reporting adverse...
German specialty chemicals group, H&R Wasag, increased its
sales and earnings in the third quarter of this year, helped by its
in-house refinery operations that allow it to counter the steady
rise in costs arising from crude oil...
Specialty chemical company Avecia featured prominently at the
recent CPhI Expo in Madrid, announcing investments and activity,
which hint at the business of custom synthesis of APIs and advanced
intermediates coming back into favour.
Sigma-Aldrich Fine Chemicals (SAFC) Biosciences chose the CPhI Expo
in Madrid to announce a series of updates concerning company
activity. The custom manufacturing group is currently undergoing
construction of a new US facility aimed...
Catch-up legislation from the EU has swept away the handicap on
European generics companies, allowing them to research copycat
drugs before patent expiry.
Drug development services company, Aptuit, has finalised a deal to
acquire InfoPro Solutions, which adds informatics services to
Aptuit's portfolio, as well as the Clinicopia Suite, which enables
customer access to drug development...
Kreatech Biotechnology launches its latest small RNA kit that
targets microRNA and siRNA arrays that directly labels any and all
sizes of naturally occurring nucleic acids without the need of
enzymes.
According to a recent report, analytic separation technology will
continue to evolve as limitations are addressed and standards grow
even more rigorous, as market drivers such as quality control,
instrument design, and software in...
A group of researchers have found that FLT-1 - a molecule
implicated in blood vessel growth - is necessary for the escape of
the leukaemia cells from the bone marrow (BM), suggesting that
blocking of this molecule pharmaceutically...
TorreyPines Therapeutics has initiated a phase I clinical trial for
its first-in-class compound, which claims to offer a non-opioid,
non-vascular approach to the management of severe pain.
Innovative laboratory technology that produces a sharper picture of
the nano-machine that translates genetic program into proteins
gives a unique insight into how some types of antibiotics work
leading to the design of better ones.
Pall Corporation has revealed a unique approach for speeding
vaccine production, which could provide a solution to the
potentially huge demand for vaccines by governments and
pharmaceutical manufacturers in response to the avian flu...
Pain Therapeutics and King Pharmaceuticals have entered into an
alliance to develop and commercialise Remoxy in an alliance worth
at least $400 million (€342 million). The deal positions the
abuse-resistant opioid painkiller as a...
Pliva released its financial results for the first nine months of
2005, which revealed a net loss of $34 million, as the drug maker
tries to recover from its loss-making drug launch in the US. This
is despite posting higher revenues...
Coremed has introduced its proprietary drug-delivery platform
technology that improves absorption of certain proteins and
macromolecules such as insulin within the gastrointestinal tract.
Last month, In-PharmaTechnologist.com reported on
Cargill-Cerestar's plans to unveil a new excipient at CPhI which is
developed on the back of a directly compressible excipient platform
allowing tablets to be produced using lower...
Dr. Reddy's Laboratories (DRL) has signed a definitive agreement to
acquire Roche's Mexican API business, in a move to drive the next
wave of growth in its custom pharmaceutical services (CPS)
business.
Cook Pharmica will be the first contract manufacturer to offer live
webcam services, an innovation that will enable both customers and
regulatory agencies to view production as it occurs.
Croda unveiled its new range of Super Refined PEG and Super Refined
Oleic Acid drug delivery excipients, claimed to enhance active
pharmaceutical ingredient (API) and formulation stability.
A simpler and more cost-effective way of obtaining high yields of
antibody fragments, which are used for research, diagnostic and
therapeutic applications may be possible after a deal was agreed to
produce the fragments in research...
Doctors and cancer researchers have pleaded with EU politicians to
support a strong REACH chemicals regulation in order to halt an
increase in cancer rates, congenital malformations and asthma.
Foss has introduced the latest in its NIRSystems analyser range,
featuring the company's XDS near-infrared (NIR) technology, for
improved analytical performance in harsh industrial manufacturing
environments.
Sophion Bioscience and Physio-Tech have signed an agreement in
which Physio-Tech will become the exclusive distributor of Qpatch
16 systems in Japan, signifying its introduction into the Asian
market.
A small molecule drug, which has been developed to treat solid
tumour and haematological cancer, has entered an Investigational
New Drug (IND) application that represents the emergence of aurora
kinase inhibitors as a viable cancer...
German biotech company Evotec OAI boosted its third quarter
revenues by 18 per cent to €19 million, despite the difficult
operating environment for companies supplying drug discovery
technologies, continuing its recovery from a weak...
Sanofi Pasteur has entered into a license and supply agreement with
Eisai for the use of their novel adjuvant designed to boost the
immune response to a broad range of vaccines.
Varian has announced it is to acquire Polymer Laboratories for $42
million (€35.7 million)in a transaction that adds consumables and
instrumentation for Gel Permeation Chromatography (GPC) analysis to
its product portfolio.
With the aim of meeting government's needs for pandemic planning,
Roche has announced it is on track to produce 300 million Tamiflu
treatments annually from 2007, after stepping up its production
capacity.
DSM is expanding its anti-infectives production facilities in
India, as part of a global restructuring program to improve
profitability and retain DSM's position in the penicillin market.
Nikon Instruments have launched a series of software and
application enhancements for spectral imaging applications, which
are used extensively in drug discovery and cell biology.
Ferro introduced its new high-purity, low-endotoxin sucrose,
maltose and trehalose sugars at the recent CPhI in Madrid, designed
to improve product quality and broaden the market for injectable
protein-based APIs.
Proditec exhibited its new automatic visual tablet inspection
system at the recent CPhI, designed to provide the first
alternative to manual pharmaceutical tablet inspection for smaller
laboratories.
Lanxess has said it will spin-off its Fine Chemicals operations
into a separate business unit that is expected to become
independent as of the second quarter next year.
New findings may have significant implications for the growing
generics drugs industry, by challenging previous assumptions that
all formulations of the same active pharmaceutical ingredient (API)
are therapeutically equivalent.
Fisher Scientific International reported it's third quarter
performance for 2005, which revealed profit had more than doubled
as a result of improved sales and fewer acquisition related
charges.
The GEA Group has completed an agreement to acquire Steris's freeze
dryer (lyophiliser) product line, in a deal that aims to strengthen
the group's Process Engineering Division in the Process Engineering
Segment.
A Phase I clinical trial, which is investigating the
pharmacological activities of a compound for the treatment of
Alzheimer's disease, has just been completed with results
indicating improved efficacy and pharmacokinetics over...
Biochip technology has redefined the process of drug discovery with
partnerships central to accelerating adoption levels and expanding
revenues in a market that is reinforced by strong bioinformatics
infrastructure and standardisation...
Contract research specialists Xceleron have announced a new
three-year deal that provides support for GSK's bioanalytical AMS
programme for human metabolite profiling and obtaining mass balance
data.
An affirmation that aims to replace the use of laboratory animals
in testing was agreed in Brussels by key industry sectors
representing the European chemical, pharmaceutical and
biotechnology industries.
A diagnostic test, which monitors anti-HIV drugs in the blood, is
set to enter development to eventually become available across
Europe. The test will be used to identify the correct dosage of
medicine for individual patients.
AssurX have launched a software process for document control, which
will enable pharmaceutical manufacturing companies to streamline
their approach to monitoring safety issues and overall quality
control efforts.
